Chordate Medical Holding AB (publ)

Stockholm Stock Exchange CMH.ST

Chordate Medical Holding AB (publ) Free Cash Flow for the year ending December 31, 2023: USD -2.80 M

Chordate Medical Holding AB (publ) Free Cash Flow is USD -2.80 M for the year ending December 31, 2023, a -15.75% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Chordate Medical Holding AB (publ) Free Cash Flow for the year ending December 31, 2022 was USD -2.42 M, a -1.70% change year over year.
  • Chordate Medical Holding AB (publ) Free Cash Flow for the year ending December 31, 2021 was USD -2.38 M, a 4.37% change year over year.
  • Chordate Medical Holding AB (publ) Free Cash Flow for the year ending December 31, 2020 was USD -2.49 M, a -24.99% change year over year.
  • Chordate Medical Holding AB (publ) Free Cash Flow for the year ending December 31, 2019 was USD -1.99 M, a 6.83% change year over year.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
Stockholm Stock Exchange: CMH.ST

Chordate Medical Holding AB (publ)

CEO Mr. Anders Weilandt
IPO Date Feb. 15, 2022
Location Sweden
Headquarters KistagAngen 20B
Employees 3
Sector Health Care
Industries
Description

Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It focuses on the ear-nose and throat area. The company was founded in 2005 and is based in Kista, Sweden.

Similar companies

CLS-B.ST

Clinical Laserthermia Systems AB (publ)

USD 0.28

-7.61%

StockViz Staff

January 15, 2025

Any question? Send us an email